PHQ-9 Score Explained: Depression Screening Results, Severity Ranges, and Next Steps
depressionmental health screeningPHQ-9psychiatrymeasurement-based care

PHQ-9 Score Explained: Depression Screening Results, Severity Ranges, and Next Steps

CClinical News Editorial Team
2026-11-17
7 min read

Learn what PHQ-9 score ranges mean, what the questionnaire cannot diagnose, and how to track symptoms, safety, function, and treatment response.

A PHQ-9 score can help organize a conversation about depressive symptoms, but it is not a diagnosis or a substitute for a clinical assessment. This guide explains the usual score ranges, what to track over time, what should happen after a low or high result, and how to prepare for follow-up care.

Overview

The Patient Health Questionnaire-9, usually called the PHQ-9, is a nine-item questionnaire about symptoms commonly associated with depression during the previous two weeks. Each item is scored from 0 to 3, producing a total score from 0 to 27. The questionnaire also asks how difficult the symptoms have made it to work, care for yourself, or get along with other people.

A PHQ-9 score is best understood as a screening result and a starting point for discussion. It cannot, by itself, establish major depressive disorder, identify the cause of symptoms, predict the right treatment, or show whether someone is safe. A clinician may consider the score alongside symptom duration, functional impact, medical history, medications, substance use, sleep, stressors, and the possibility of other mental or physical health conditions.

PHQ-9 totalCommon descriptionWhat it usually suggests
0–4MinimalFew or no depressive symptoms reported; context still matters.
5–9MildSome symptoms are present and may warrant monitoring, support, or further assessment.
10–14ModerateA clinical assessment is generally appropriate, especially if symptoms affect daily life.
15–19Moderately severePrompt evaluation and a discussion of treatment options are important.
20–27SeverePrompt clinical assessment is important, including a direct safety evaluation.

These ranges are descriptive rather than absolute rules. Two people with the same total may need different next steps. A lower score can still represent serious distress, particularly when symptoms are new, rapidly worsening, or associated with thoughts of self-harm. A higher score does not automatically mean that medication is required or that hospitalization is necessary. The result should guide—not replace—clinical judgment.

What to track

Tracking more than the total score makes the PHQ-9 more useful. Keep a simple record that you can review with a clinician.

1. The total score and each item

Record the date, total score, and responses to the individual questions if available. The same total can arise from different symptom patterns. For example, one person may report mainly sleep and fatigue problems, while another reports low mood, loss of interest, and difficulty concentrating. Item-level changes can help identify which symptoms are improving and which remain troublesome.

Item 9 asks about thoughts that you would be better off dead or of hurting yourself. Any response other than “not at all” deserves direct follow-up rather than being treated as just another point in the total. A clinician may ask about the nature of the thoughts, intent, access to means, past attempts, protective factors, and immediate support.

If you may act on thoughts of suicide or self-harm, cannot stay safe, or are in immediate danger, contact local emergency services or go to the nearest emergency department. If possible, stay with a trusted person and reduce access to anything you could use to hurt yourself. In the United States or Canada, calling or texting 988 connects with a crisis service; elsewhere, use the appropriate local crisis or emergency number.

3. Functioning

Note what symptoms are doing to everyday life: missed work or school, difficulty completing basic tasks, reduced self-care, relationship strain, withdrawal, or problems with concentration. Function can improve before the score returns to a low range, or remain impaired even when the score changes only slightly.

Track sleep duration and quality, appetite, energy, activity, anxiety, irritability, substance use, pain, and major stressors when relevant. Also record treatment changes, missed doses, therapy appointments, side effects, and significant life events. This context helps distinguish a meaningful symptom trend from a temporary change caused by illness, disrupted sleep, or an unusual week.

A practical tracking template

For each check-in, record: date; PHQ-9 total; item 9 response; the two most disruptive symptoms; hours or quality of sleep; ability to complete usual responsibilities; treatment or medication changes; side effects; and one question for the clinician. Avoid completing the questionnaire repeatedly in a single day to chase a particular number. Consistent timing and honest answers are more useful than frequent testing.

Cadence and checkpoints

The right interval depends on the situation. A person monitoring mild symptoms may review them periodically, while someone starting or changing treatment may need earlier contact with a clinician. Follow the schedule recommended by the treating professional rather than using a score alone to decide when care is needed.

Before or during the first assessment

Bring the completed questionnaire, a medication and supplement list, relevant medical conditions, and a short description of when symptoms began. A clinician may assess depression symptoms alongside bipolar-spectrum symptoms, anxiety, trauma-related symptoms, substance use, sleep disorders, medication effects, thyroid or other medical issues, and grief or situational stress. This broader assessment matters because treatments that help one condition may not be appropriate for another.

After starting or changing treatment

Use the PHQ-9 as one measure of response, not the only one. At follow-up, compare the current score with the starting score, but also discuss functioning, adverse effects, adherence, expectations, and safety. Improvement may be gradual, uneven, or concentrated in particular symptoms. A lack of improvement should lead to a treatment review—not self-directed dose changes or abrupt discontinuation of prescribed medication.

During stable monitoring

When symptoms and treatment are stable, periodic reassessment can help identify early relapse or confirm continued benefit. The frequency may be monthly, quarterly, or tied to clinical visits, depending on individual needs. A sudden change in mood, functioning, sleep, substance use, or safety concerns should prompt earlier contact regardless of the planned schedule.

How to interpret changes

Look for a pattern across time rather than attaching too much meaning to one result. A change of a few points may reflect ordinary day-to-day variation, differences in how questions were understood, or a short-term stressor. A sustained change, a change across several symptoms, or a noticeable shift in functioning is more useful for treatment discussions.

Ask these questions when comparing scores:

  • Was the questionnaire completed under similar conditions and for the same two-week period?
  • Which individual symptoms changed, and did the change match how daily life feels?
  • Has sleep, physical health, substance use, medication, or another major stressor changed?
  • Are symptoms improving while side effects, agitation, or safety concerns are worsening?
  • Did the score change without a corresponding improvement in work, relationships, self-care, or other goals?

A lower score is encouraging but does not prove that depression has resolved. A higher score may reflect worsening depression, a new stressor, a medical problem, treatment interruption, or a different condition. Conversely, a high score should not be dismissed because someone appears calm or is still functioning at work. Report important changes directly to a clinician.

People with a history of periods of unusually elevated or irritable mood, much less need for sleep, racing thoughts, impulsive behavior, or markedly increased activity should mention this before beginning or changing depression treatment. Those features can change the diagnostic assessment and treatment plan.

For a broader explanation of how screening results guide follow-up, see Screening Test Results Explained: Positive, Negative, False-Positive, and Follow-Up Decisions. To compare therapy, medication, and combined care, review Understanding Mental Health Treatment Evidence.

When to revisit

Revisit your PHQ-9 record at the next planned mental-health appointment, after a meaningful treatment change, or when symptoms or functioning change. A practical monthly or quarterly review can be useful for ongoing monitoring, but the schedule should be individualized. The article and any screening instructions should also be reviewed when clinical guidance, questionnaire administration requirements, or crisis-support information changes.

Contact a clinician sooner than planned if symptoms are rapidly worsening, daily responsibilities are becoming difficult, medication side effects are concerning, sleep and energy change dramatically, or anxiety, substance use, or agitation increases. Seek urgent help for immediate safety concerns, suicidal intent, a recent self-harm act, or inability to care for basic needs.

Before your next appointment, complete one questionnaire as instructed, bring your score history, mark item 9 clearly, and write down the three most important changes since the previous visit. Ask: “What might explain this change?”, “What is our treatment goal?”, “When should we check again?”, and “What should I do if symptoms worsen?” Used this way, the PHQ-9 becomes a structured communication tool for measurement-based care—not a label, a pass-or-fail test, or a substitute for help.

Related Topics

#depression#mental health screening#PHQ-9#psychiatry#measurement-based care
C

Clinical News Editorial Team

Health Editor

Senior editor and content strategist. Writing about technology, design, and the future of digital media. Follow along for deep dives into the industry's moving parts.